{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=17", "query": { "intervention": "Low Dose Drug A", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 1207, "total_pages": 121, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T13:00:46.622Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03721900", "title": "Ketamine for Major Depressive Disorder", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "SHX-001 Active low dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "SHX-001 Active High dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shenox Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 14, "start_date": "2018-12-28", "completion_date": "2019-06-06", "has_results": false, "last_update_posted_date": "2019-04-25", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 3, "location_summary": "Gaithersburg, Maryland • Boston, Massachusetts • Dayton, Ohio", "locations": [ { "city": "Gaithersburg", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03721900" }, { "nct_id": "NCT01502644", "title": "Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Low Back Pain", "Degenerative Disc Disease", "Depression", "Anxiety" ], "interventions": [ { "name": "Oxycodone", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 81, "start_date": "2009-02", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2017-07-11", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 1, "location_summary": "Chestnut Hill, Massachusetts", "locations": [ { "city": "Chestnut Hill", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01502644" }, { "nct_id": "NCT05902169", "title": "Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glioblastoma", "Recurrent Glioblastoma", "GBM" ], "interventions": [ { "name": "SonoCloud-9 (SC9)", "type": "DEVICE" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Lomustine", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "CarThera", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 560, "start_date": "2024-01-29", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Los Angeles, California • San Francisco, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05902169" }, { "nct_id": "NCT00203879", "title": "Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Melanoma" ], "interventions": [ { "name": "MAGE-3/Melan-A/gp100/NA PBMC, rhIL-12 (drug)", "type": "DRUG" }, { "name": "MAGE-3/Melan-A/gp100/NA17 Peptide-pulsed autologous PBMC, rhIL-12 with IL-2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2002-02", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2013-09-05", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00203879" }, { "nct_id": "NCT01719003", "title": "Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2", "Hyperglycemia" ], "interventions": [ { "name": "Metformin 500 mg bid", "type": "DRUG" }, { "name": "Metformin 1000 mg bid", "type": "DRUG" }, { "name": "Empagliflozin low dose qd", "type": "DRUG" }, { "name": "Empagliflozin high dose qd", "type": "DRUG" }, { "name": "Empagliflozin low dose bid", "type": "DRUG" }, { "name": "Empagliflozin high dose bid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1413, "start_date": "2012-10", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-02-19", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Manley Hot Springs, Alaska • Glendale, Arizona + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Manley Hot Springs", "state": "Alaska" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Searcy", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01719003" }, { "nct_id": "NCT00892723", "title": "A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scar Prevention", "Scar Reduction" ], "interventions": [ { "name": "AZX100 Drug Product", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Capstone Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 59, "start_date": "2009-05", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2012-10-11", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 3, "location_summary": "Pasadena, California • Philadelphia, Pennsylvania • Austin, Texas", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00892723" }, { "nct_id": "NCT00135668", "title": "Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypotension" ], "interventions": [ { "name": "Nitroprusside", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Emmes Company, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "17 Years", "sex": "ALL", "summary": "Up to 17 Years" }, "enrollment_count": 211, "start_date": "2005-08", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00135668" }, { "nct_id": "NCT04439695", "title": "Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Low dose", "type": "BIOLOGICAL" }, { "name": "Intermediate dose", "type": "BIOLOGICAL" }, { "name": "High dose", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "KBio Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 120, "start_date": "2020-06-25", "completion_date": "2021-07-28", "has_results": false, "last_update_posted_date": "2021-09-16", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04439695" }, { "nct_id": "NCT02246075", "title": "Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease", "Dementia", "Cognition" ], "interventions": [ { "name": "EVP-6124", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FORUM Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2015-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-10-15", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 2, "location_summary": "Delray Beach, Florida • Albuquerque, New Mexico", "locations": [ { "city": "Delray Beach", "state": "Florida" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02246075" }, { "nct_id": "NCT06063330", "title": "Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID-19", "Infectious Disease", "Symptomatic COVID-19 Infection Laboratory-Confirmed", "SARS CoV 2 Infection" ], "interventions": [ { "name": "RQ-001", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "COMBINATION_PRODUCT", "OTHER" ], "sponsor": "Red Queen Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 66, "start_date": "2023-09-27", "completion_date": "2024-01-03", "has_results": false, "last_update_posted_date": "2024-01-11", "last_synced_at": "2026-11-15T13:00:46.622Z", "location_count": 6, "location_summary": "Los Angeles, California • Miami, Florida • Baltimore, Maryland + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06063330" } ] }